Gain valuable insights into the pharmaceutical and chemical processing industries through an exclusive interview with Frederic Dietrich, Managing Director of Dec Group.
Discover the true meaning of "End-to-End" and what sets our approach apart.
May 13, 2026 - Dec Group is pleased to announce that Alconbury Weston Ltd (AWL) has officially been renamed Dec Continuous Process Ltd, marking the final step in the company’s full integration into the Group following its acquisition in 2022. The incorporation of AWL’s capabilities into the Dec Group strengthened a shared commitment to advancing continuous manufacturing and advanced processing solutions. By combining AWL’s proven process technologies with Dec’s global leaders
May 11, 2026 - We are delighted to announce the official opening of Dec Brasil, marking a significant milestone in expanding our footprint and strengthening our support capabilities across Brazil and the wider South American region. This new subsidiary reinforces our long‑term commitment to serving customers locally with greater proximity. For years, our customers in Latin America have trusted Dec for innovation and reliability. Now, with a dedicated local team, we can bring
If you had to pinpoint the most overlooked step in producing life‑saving parenteral therapies, what would it be? The formulation itself? The sterile environment? Or could it be something far more operational - the moment an empty IV bag enters the filling line? In many pharmaceutical facilities, that moment is where the real story begins. The pressure is on: rising demand for flexible, high‑quality therapies, tighter regulatory expectations, and the constant push to do more w